Close Menu

There is certainly no shortage of ambition in the Chinese pharmaceutical industry, says In the Pipeline's Derek Lowe. But does it have the resources and wherewithal to follow through? China already has a substantial contract research industry, and it seems clear, Lowe says, that a Chinese Merck or a Chinese Novartis eventually will exist.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.